Weronika Dardzinska | Signal Evaluation and Risk Management Specialist, Safety Lead
GSK

Day 1 - World Drug Safety Congress Americas 2025 @ 11:40

Presentation: What Your Statistician Won’t Tell You: 7 Common Stat Traps in Pharmacovigilance (and How to Beat Them)

 In pharmacovigilance (drug safety), we rely on data to detect and assess adverse drug reactions. But data can mislead if we’re not careful - even if you have a statistician on your team. There are certain statistical pitfalls (“stat traps”) that drug safety professionals may fall into when interpreting safety data. Often, a busy statistician might not explicitly warn you about these, assuming they’re understood. Below we’ll explore seven of the most common stat traps in pharmacovigilance and how to avoid them, using clear examples and storytelling to make the statistics more approachable and memorable. No formulas- just clear visuals and practical guardrails.

Weronika Dardzinska, Signal Evaluation and Risk Management Specialist, Safety Lead, GSK

×

Weronika Dardzinska / Presentation: What Your Statistician Won’t Tell You: 7 Common Stat Traps in Pharmacovigilance (and How to Beat Them)

Weronika Dardzinska, Signal Evaluation and Risk Management Specialist, Safety Lead,
GSK

Weronika Dardzińska, PhD, DVM is a pharmacovigilance and clinical-development leader with over 15 years of global experience in drug‑safety science, AI‑driven data review and front‑line patient care. She has deep therapeutic expertise in oncology (NSCLC, multiple myeloma) and respiratory disease...

CloseMore